FDA Would Lose Direct Access To User Fees Under House Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA would lose the ability to negotiate with user fee payors on use of the funds under legislation introduced by Rep. Hinchey (D-N.Y.). The bill also would place restrictions on advisory committee members with financial ties to the industry.
You may also be interested in...
Drug Safety Act Expands Withdrawal Authority; Final Decision Rests With Commissioner
The proposed FDA Safety Act would enable the Center for Postmarket Drug Evaluation & Research to call for a drug's withdrawal, with final authority retained by the FDA commissioner
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation
Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products
FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation